<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
ArQule, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.01 par value
- --------------------------------------------------------------------------------
(Title of Class of Securities)
04269E107
--------------------------------------------
(CUSIP Number)
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that
section of the Act but shall be subject to all other provisions of the Act
(however, see the Notes).
<PAGE> 2
CUSIP No. 04269E107 13G Page 2 of 3 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Physica B.V.
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) /X /
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
The Netherlands
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF
907,734 shares
SHARES -------------------------------------------------
6 SHARED VOTING POWER
BENEFICIALLY
OWNED BY -0-
------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING
907,734 shares
PERSON ------------------------------------------------
8 SHARED DISPOSITIVE POWER
WITH
-0-
- -------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
907,734 shares
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
10.11%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
CO
- --------------------------------------------------------------------------------
-2-
<PAGE> 3
Item 1(a) NAME OF ISSUER: ArQule, Inc.
Item 1(b) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
200 Boston Avenue
Medford, Massachusetts 02155
Item 2(a) NAME OF PERSON FILING: Physica B.V.
Item 2(b) ADDRESS OF PRINCIPAL BUSINESS OFFICE:
C.J. van Houtenlaan, 36
1381 CD Weiss
The Netherlands
Item 2(c) CITIZENSHIP: Not Applicable
Item 2(d) TITLE OF CLASS OF SECURITIES: Common Stock, $.01 par value
Item 2(e) CUSIP NUMBER: 04269E107
Item 3 TYPE OF REPORTING PERSON: Not Applicable
Item 4 OWNERSHIP:
(a) AMOUNT BENEFICIALLY OWNED: 907,734 shares
(b) PERCENT OF CLASS: 10.11%
(c) (i) Sole Voting Power: 907,734 shares
(ii) Shared Voting Power: -0-
(iii) Sole Dispositive Power: 907,734 shares
(iV) Shared Dispositive Power: -0-
Item 5 Not Applicable
Item 6 Not Applicable
Item 7 Not Applicable
Item 8 Not Applicable
Item 9 Not Applicable
Item 10 Not Applicable
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is truer, complete
and correct.
Feb. 11th, 1997
---------------
Date
PHYSICA B.V.
/s/ Dr. Jan Willem Frederick van Ingen
--------------------------------------
Dr. Jan Willem Frederick van Ingen
Director
Page 3 of 4 pages
